Relationship between relative dose intensity and mortality in women receiving combination chemotherapy for stage III-IV epithelial ovarian cancer.
L. J. Havrilesky
No relevant relationships to disclose
R. K. Hanna
No relevant relationships to disclose
M. S. Poniewierski
No relevant relationships to disclose
R. Laskey
No relevant relationships to disclose
A. A. Secord
No relevant relationships to disclose
P. A. Gehrig
No relevant relationships to disclose
M. A. Lopez
No relevant relationships to disclose
A. Shafer
No relevant relationships to disclose
L. Van Le
No relevant relationships to disclose
D. C. Dale
No relevant relationships to disclose
J. Crawford
Consultant or Advisory Role - Amgen
Research Funding - Amgen
* G. H. Lyman
Research Funding - Amgen